TABLE 1 

Epidemiological, clinical, and host characteristics of the patients

PatientSexOriginHospitalTransmissionaYr first
HIV-1+
Sample
date
GroupViral load
(copies/ml)
CD4+ count
(T cells/µl)
HLA-B
genotype
LTNP_1FMadridC. S. SandovalIDU19902005LTNP-VCs125628B1501/B2705
LTNP_3MMadridC. S. SandovalIDU19882005LTNP-ECs<50880B2705/B5801
LTNP_5MMadridC. S. SandovalIDU19862005LTNP-ECs<50559B2705/B3503
LTNP_RF_15MMadrid12 de OctubreIDU19892004LTNP-ECs<50460B44/B57
LTNP_RF_21MMadrid12 de OctubreIDU19852004LTNP-ECs<50690B47/B14
AS7FNKbEl PatriarcaIDU19891989NKNKNKB3501/B5101
I_10FMadridC. S. SandovalIDU/HTNK1993Progressors8.9 × 104251
IV_10MVigoIDU19911994Progressors1.7 × 106342
I_14FMadridC. S. SandovalIDU/HT19871994Progressors1.3 × 105337
RIS_06MMadridC. S. SandovalMSM20052005Progressors7.6 × 104436
  • a Transmission route: IDU, intravenous drug user; MSM, men who have sex with men; HT, heterosexual.

  • b NK, not known.